Page 131 - Read Online

Novotny et al. Vessel Plus 2022;6:51 Vessel Plus
DOI: 10.20517/2574-1209.2021.139

Original Article Open Access

Preoperative atrial fibrillation/flutter impact on risk-

adjusted repeat aortic intervention patients

1
2
3
3
1
1
Samantha Novotny , Julia Dokko , Xiaoyue Zhang , Sohaib Agha , Ashutosh Yaligar , Natalie Kolba ,
4
1
3
3
3,#
Vineet Tummala , Puja B. Parikh , Aurora D. Pryor , Henry J. Tannous , A. Laurie Shroyer , Thomas
Bilfinger 3,#
1
Renaissance School of Medicine, Undergraduate Medical Education, Stony Brook University, Stony Brook, NY 11794, USA.
2
Renaissance School of Medicine, Office of Dean, Stony Brook University, Stony Brook, NY 11794, USA.
3
Department of Surgery, Stony Brook University Hospital, Stony Brook, NY 11794-8191, USA.
4
Department of Medicine, Stony Brook University Hospital, Stony Brook, NY 11794, USA.
#
Authors contributed equally.
Correspondence to: Prof. A. Laurie Shroyer, Department of Surgery, Stony Brook University Hospital, Medical and Research
Translation (MART) building, 08-0814, 100 Nicolls Road, Stony Brook, NY 11794-8191, USA. E-mail:
AnnieLaurie.Shroyer@stonybrookmedicine.edu
How to cite this article: Novotny S, Dokko J, Zhang X, Agha S, Yaligar A, Kolba N, Tummala V, Parikh PB, Pryor AD, Tannous HJ,
Shroyer AL, Bilfinger T. Preoperative atrial fibrillation/flutter impact on risk-adjusted repeat aortic intervention patients. Vessel
Plus 2022;6:51. https://dx.doi.org/10.20517/2574-1209.2021.139
Received: 18 Nov 2021 First Decision: 26 Jan 2022 Revised: 2 Feb 2022 Accepted: 1 Mar 2022 Published: 2 Sep 2022
Academic Editor: Frank W. Sellke Copy Editor: Peng-Juan Wen Production Editor: Peng-Juan Wen
Abstract
Aim: Impacts of pre-operative atrial fibrillation or flutter (AF/AFL) upon repeat aortic valve replacement (r-AVR)
patients’ risk-adjusted short-term outcomes is unknown.
Methods: From 2005-2018, New York State AF/AFL versus non-AF/AFL adults’ risk-adjusted r-AVR outcomes
were compared. Primary endpoints included the Society of Thoracic Surgeons’ 30-day operative mortality or major
morbidity (MM) composite and 30-day readmission (READMIT); the MM sub-components were secondary
endpoints. Multivariable logistic regression models evaluated AF/AFL impact upon these endpoints while holding
other factors constant.
Results: Of 36,783 adults initially undergoing aortic valve replacement, 334 subsequently underwent r-AVR.
Within this r-AVR group, 42.4% of repeat surgical (r-SAVR) patients had AF/AFL; 50.4% of repeat transcatheter
(viv-TAVR) patients had AF/AFL. R-SAVR AF/AFL patients were older and had more comorbidities than those
without AF/AFL. Viv-TAVR AF/AFL patients were similar to those without AF/AFL except for lower rates of
chronic obstructive pulmonary disease. Comparing risk-adjusted r-AVR outcomes, AF/AFL did not impact MM

© The Author(s) 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0
International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing,
adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as
long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and
indicate if changes were made.

www.vpjournal.net